Barely Significant
← all phrases

“nearly significant”

3,288 sentences · 3,288 papers · 3,853 search hits before verification · confirmed specimen

Sighted at

p=0.0579p=0.06

Listed by Hankins, posted since · Hankins (2013) · Otte et al. (2022)

In the literature

(PLos One, 7:48663, 2012), our method identified 2 nearly significant genes ( APOA5 and ZNF259 ) near rs964184, whereas neither the other gene-level tests nor the standard test on each individual single-nucleotide polymorphism (SNP) detected any significant gene in a genome-wide scan.
A multi-country study by Simpson-Yap et al., published as a pre-print, which included 2,340 MS patients with SARS-CoV-2 infection, identified an increased risk for hospitalization, ICU admission, and ventilator use with rituximab (OR, 2.43; 95% CI, 1.48–4.02; OR, 3.93; 95% CI, 1.56–9.89; OR, 4.00; 95% CI, 1.54–10.39, respectively) and an increased risk for hospitalization with ocrelizumab (OR, 1.56; 95% CI:, 1.01–2.41), when compared to dimethyl fumarate; the risk for ICU admission with ocrelizumab was nearly significant (OR, 2.30; 95%, 0.98–5.39).
= 1, p = 0.006). From a within-group perspective, the only nearly significant within-group effect was the positive relation between number of males and territory size (model 1B; figure 1 d ; electronic supplementary material, table S2; estimate ± s.e. = 1.10 ± 0.48, d.f. = 1, p = 0.052), suggesting that increasing number of males within the group predicts an increase of the group's territory.
We tried to identify genetic factors associated with the number of TE genes and lincRNAs expressed using genome-wide association study (GWAS) but could not see any clear association, except for 1 nearly significant peak on chromosome 2 near the XERICO gene (At2g04240), encoding a protein with a zinc finger domain ( Supplemental Fig.
Outcomes were assessed as follows: 1) weight loss post-viral infection, 2) viral titers at the terminal endpoints, 3) gross lung discoloration at the terminal endpoints post-infection, and 4) histopathological scoring of lung samples. Mice administered V2043 at the 60 mg/kg dose and QD +12h dosing schedule showed significant protection from weight loss on days 3 and 4 post-infection and nearly significant protection from weight loss on day 5 post-infection ( Figure 2 B).